Fig. 4
From: Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models
Relative expression of serum microRNAs in disease progression, from PDAC patients of stage I to stage IV; *p < 0.05; **p < 0.01; ***p < 0.001